Rap2 belongs to the Ras family of small GTP-binding proteins, but its specific roles in cell signaling remain unknown. In the present study, we have affinity-purified from rat brain a Rap2-interacting protein of ϳ155 kDa, p155. By liquid chromatography tandem mass spectrometry, we have identified p155 as Traf2-and Nck-interacting kinase (TNIK). TNIK possesses an N-terminal kinase domain homologous to STE20, the Saccharomyces cerevisiae mitogen-activated protein kinase kinase kinase kinase, and a C-terminal regulatory domain termed the citron homology (CNH) domain. TNIK induces disruption of F-actin structure, thereby inhibiting cell spreading. In addition, TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway. Among our observations, TNIK interacted with Rap2 through its CNH domain but did not interact with Rap1 or Ras. TNIK interaction with Rap2 was dependent on the intact effector region and GTP-bound configuration of Rap2. When co-expressed in cultured cells, TNIK colocalized with Rap2, while a mutant TNIK lacking the CNH domain did not. Rap2 potently enhanced the inhibitory function of TNIK against cell spreading, but this was not observed for the mutant TNIK lacking the CNH domain. Rap2 did not significantly enhance TNIKinduced JNK activation, but promoted autophosphorylation and translocation of TNIK to the detergentinsoluble cytoskeletal fraction. These results suggest that TNIK is a specific effector of Rap2 to regulate actin cytoskeleton.Rap2 is a member of the Ras family of small GTP-binding proteins, which regulate a range of cellular processes including cell proliferation, differentiation, and cytoskeletal rearrangement (for a review, see Ref. 1). To regulate these processes, Ras family proteins cycle between GTP-bound active and GDPbound inactive forms. In the GTP-bound active form, Ras family proteins physically interact with downstream effectors and thereby regulate their subcellular localization and activity (1). For instance, GTP-bound Ras interacts with effectors including Raf-1, B-raf, Ral guanine nucleotide dissociation stimulator During interaction with effectors, the effector regions of Ras family proteins (amino acids 32-40 in the case of Ras) serve as binding interfaces; thus, mutations within their effector regions impair interaction with effectors (Refs. 1-4, reviewed in Ref. 6). The effector regions are also critical for the differential recognition of effectors. For instance, the effector region of Rap1, a close relative of Rap2, is identical to that of Ras. Rap1 interacts with effectors of Ras, and sometimes counteracts Rasmediated signaling (1, 2). For example, Rap1 regulates the extracellular signal-regulated kinase (ERK) pathway, the "classical" mitogen-activated protein kinase (MAPK) pathway, through Raf-1 and B-raf. Although Rap1 interacts with Raf-1 and B-raf, it only activates B-raf. In fibroblasts, Rap1 inhibits Ras-induced cellular transformation. Rap1 exerts this action presumably by trapping Raf-1 in an inactive complex, thereby inhibiting ERK activation (1...

No abstract

Downregulation of CRYAA, SOD1, and TPI1, observed here after a short period of DEX-induced ocular hypertension, may be involved in the onset of neural damage in steroid-induced glaucoma.

Purpose: To investigate global protein expression profiles in the trabecular meshwork (TM) of normal and glucocorticoid-induced ocular hypertensive rat eyes by proteomic analysis, which has not yet been conducted to date. Materials and Methods: A rat ocular hypertension model was produced by topical application of dexamethasone (DEX) for 4 weeks. Age-matched untreated rats served as controls. Intraocular pressure (IOP) was monitored by an electronic tonometer. TM protein expression profiling and protein identification was carried out by a two-dimensional fluorescence differential gel electrophoresis (2-D DIGE) system and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, respectively. Results: In DEX-treated rats, average IOP was elevated significantly, as compared with controls. By the DEX treatment, 14 TM protein spots were up- or downregulated consistently in 2-D DIGE analyses. Proteins exhibiting more than 2-fold statistically significant change were identified by MALDI-TOF mass spectrometry. αA-Crystallin and βA₃-crystallin were upregulated, while the C-propeptides of type I collagen were downregulated. Conclusion: Relatively short-term glucocorticoid application induced alteration in the expression of a number of proteins, including downregulation of type I collagen C-propeptides. This could reflect impaired collagen turnover in the TM of glucocorticoid-treated eyes.

No abstract